logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jiehai Yu

Guangdong Provincial Clinical Research Center for Cancer
H指数:10
被引数:534

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study

新辅助放化疗联合辛替利单抗治疗PD-L1 tps ≥ 1% 或cps ≥ 1的pMMR/MSS直肠癌患者: 一项开放标签的前瞻性II期研究

npj Precision Oncology
IF8
2025-07-120
OAAI
Zhenlin Hou; Leen Liao; Weiwei Xiao; Qiaoqi Sui; Kai Han; Binyi Xiao; Yuan Li; Weijian Mei; Jiehai Yu; Zhigang Hong; Qichen Chen; Ruyue Song; Dandan Li; Xiaoshi Zhang; Qiaoxuan Wang; Zhizhong Pan; Wu Jiang; Peirong Ding
The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

基于奥沙利铂的辅助化疗对错配修复缺陷的高危II期结肠癌的影响: 一项回顾性研究

BMC CANCER
IF3.4
2024-02-021
OAAI
Liao, Leen; Tang, Jinghua; Hong, Zhigang; Jiang, Wu; Li, Yuan; Kong, Lingheng; Han, Kai; Hou, Zhenlin; Zhang, Chenzhi; Zhou, Chi; Zhang, Linjie; Sui, Qiaoqi; Xiao, Binyi; Mei, Weijian; Yu, Jiehai; Yang, Wanjun; Pan, Zhizhong; Ding, Pei-Rong
Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer

炎症促进高微卫星不稳定性结直肠癌对免疫检查点抑制剂的抵抗

NATURE COMMUNICATIONS
IF15.7
2022-11-2859
OAAI
Sui, Qiaoqi; Zhang, Xi; Chen, Chao; Tang, Jinghua; Yu, Jiehai; Li, Weihao; Han, Kai; Jiang, Wu; Liao, Leen; Kong, Lingheng; Li, Yuan; Hou, Zhenlin; Zhou, Chi; Zhang, Chenzhi; Zhang, Linjie; Xiao, Binyi; Mei, Weijian; Xu, Yanbo; Qin, Jiayi; Zheng, Jian; Pan, Zhizhong; Ding, Pei-Rong

研究方向

暂未获取到该数据
W
Wei-Jian Mei
H 指数:12论文数:28被引数:597
P
Peirong Ding
H 指数:28论文数:198被引数:3,141
B
Binyi Xiao
H 指数:16论文数:58被引数:751
K
Kai Han
H 指数:20论文数:70被引数:2,395
唐敬华 封面图
唐敬华
H 指数:18论文数:63被引数:1,127
Z
Zhizhong Pan
H 指数:40论文数:351被引数:6,369
P
Peixin Dong
H 指数:38论文数:106被引数:4,499
N
Noriaki Sakuragi
H 指数:55论文数:365被引数:1.1万
Q
Qiaoqi Sui
H 指数:13论文数:31被引数:662
H
Hidemichi Watari
H 指数:54论文数:342被引数:1.3万